45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
14,730
Insurances with rates
3
CPT / HCPCS codes
12,998
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| C1767 | HC IMPLANT NEUROSTIM GENERATOR | $124,841 | $49,937 | — | — | 6 |
| C1882 | HC IMPLANT AICD OTHER | $113,573 | $45,429 | — | — | 5 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $108,194 | $43,278 | — | — | 6 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $100,211 | $40,084 | — | — | 12 |
| 33249 | HC INSERT/REPLACE (ICD) SINGLE/DUAL LEAD/S SYSTEM | $98,945 | $39,578 | — | — | 6 |
| J3357 | USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE | $97,450 | $38,980 | — | — | 5 |
| J9281 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT | $82,845 | $33,138 | — | — | 7 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $82,185 | $32,874 | — | — | 12 |
| C2616 | YTTRIUM-90 BRACHYTX SRC NON-STRANDED | $79,875 | $31,950 | — | — | 7 |
| C1813 | HC IMPLANT GU PENILE INFL | $72,611 | $29,045 | — | — | 5 |
| A9543 | Y-90 ZEVALIN | $70,810 | $28,324 | — | — | 7 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $69,000 | $27,600 | — | — | 7 |
| 33287 | HC RMVL & REPLCMNT PHRENIC NERVE STIM PULSE GEN | $67,856 | $27,142 | — | — | 7 |
| 33276 | HC INSERT PHRENIC NERVE STIM SYS W/ IMAGING GDNCE | $67,856 | $27,142 | — | — | 7 |
| 64568 | HC INCIS/IMPLANT CRANIAL NERVE STIM ELECTRODE | $66,735 | $26,694 | — | — | 6 |
| J7311 | FLUOCINOLONE 0.59 MG INTRAVITREAL IMPLANT | $66,588 | $26,635 | — | — | 6 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $65,105 | $26,042 | — | — | 6 |
| C1722 | HC IMPLANT AICD SINGLE | $60,527 | $24,211 | — | — | 5 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE | $60,331 | $24,132 | — | — | 6 |
| C1721 | HC IMPLANT AICD DUAL | $58,891 | $23,556 | — | — | 5 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $55,721 | $22,288 | — | — | 7 |
| 37227 | HC REVASC ARTERIAL FEM/POP W ATHERECT & STENT W/WO ANGIOPLAS | $51,717 | $20,687 | — | — | 12 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $50,864 | $20,345 | — | — | 6 |
| Q4104 | HC SKIN SUBST INTEGRA BMWD SQ CM | $48,816 | $19,526 | — | — | 6 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $47,513 | $19,005 | — | — | 7 |
| 50695 | HC URET PLACE STENT NEW W NEPH | $46,700 | $18,680 | — | — | 13 |
| 33264 | HC REPLACE GENERATOR ONLY (ICD) MULTIPLE | $45,898 | $18,359 | — | — | 7 |
| C9602 | HC COR ATHERECTOMY & DRUG-ELUTING STENT INITAL VES | $43,555 | $17,422 | — | — | 6 |
| C9775 | HC REVASC INTRAVASC LITHOTRIPSY W/WO PTA W/STENT W/ ATHERECTOMY TIB/PERO ARTERY(IES) ONLY | $41,588 | $16,635 | — | — | 7 |
| C9767 | HC REVASC INTRAVASCULAR LITHOTRIPSY W/WO PTA W/STENT & ATHERECTOMY ILIO/FEM/POP VESSEL(S) | $41,588 | $16,635 | — | — | 6 |
| 33263 | HC REPLACE GENERATOR ONLY (ICD) DUAL | $41,279 | $16,511 | — | — | 7 |
| 33262 | HC REPLACE GENERATOR ONLY (ICD) SINGLE | $41,279 | $16,511 | — | — | 7 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $39,557 | $15,823 | — | — | 7 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $37,846 | $15,138 | — | — | 6 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $37,121 | $14,848 | — | — | 7 |
| 37238 | HC PLC STENT VEN W/WO ANPL INI | $36,700 | $14,680 | — | — | 19 |
| J2329 | UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION | $36,654 | $14,662 | — | — | 7 |
| C2621 | HC IMPLANT PACER OTHER | $36,641 | $14,656 | — | — | 6 |
| J3285 | TREPROSTINIL SODIUM 2.5 MG/ML INJECTION SOLUTION | $36,290 | $14,516 | — | — | 13 |
| 47540 | HC BILIARY PLACE STENT NEW W DRN | $36,196 | $14,478 | — | — | 7 |
| C9774 | HC REVASC INTRAVASC LITHOTRIPSY W/WO PTA W/ATHERECTOMY TIB/PERO ARTERY(IES) ONLY | $35,614 | $14,246 | — | — | 6 |
| C9766 | HC REVASC INTRAVASCULAR LITHOTRIPSY W/WO PTA W/ATHERECTOMY ILIO/FEM/POP VESSEL(S) | $35,614 | $14,246 | — | — | 6 |
| 36225 | HC CATH PLC SUBCLV W VERT | $35,474 | $14,189 | — | — | 12 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $34,993 | $13,997 | — | — | 6 |
| 37231 | HC REVASC ARTERIAL TIB/PER W ATHERECT & STENT W/WO ANGIOPLAS INITIAL VES | $34,518 | $13,807 | — | — | 6 |
| A9604 | SAMARIUM-153 LEXIDRONAM | $34,493 | $13,797 | — | — | 6 |
| 0620T | HC REVASC VENOUS TIB/PER ARTERIALIZATION | $34,478 | $13,791 | — | — | 7 |
| J2327 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $34,321 | $13,728 | — | — | 6 |
| J9203 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $34,126 | $13,650 | — | — | 6 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $33,926 | $13,570 | — | — | 6 |
Showing top 50 of 14,730 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.